Citable filing context
ALGN's research view summarizes recent SEC filing context, starting with business from Feb 27, 2026.
| Filed | Item | Context |
|---|---|---|
| Feb 27, 2026 | business | Align Technology operates a global medical device business centered on the Align Digital Platform, which integrates Invisalign clear aligners, iTero intraoral scanners, and exocad CAD/CAM software. The company reports two operating segments: Clear Aligner, accounting for approximately 80% of net revenues, and Systems and Services, representing 20%. Align targets orthodontists, general practitioners (GPs), and dental support organizations (DSOs), aiming to increase its 10% global share of the 22 million annual orthodontic case starts. Strategic growth drivers include international expansion across more than 100 countries and increasing GP adoption. Recent innovations include the iTero Lumina scanner, AI-driven X-ray Insights, and the acquisition of Cubicure to enable direct 3D printing, which reduces reliance on molds and resin. Manufacturing is diversified across Mexico, China, and Poland to mitigate regional disruptions. However, the company faces significant concentration risk due to single or sole-source suppliers for critical resins, polymers, and stereolithography equipment. Additionally, operations in Mexico and North America are exposed to climate-related risks, including water stress and extreme weather events, which could impact production continuity. |
| Feb 27, 2026 | mda | Align Technology operates through two primary segments: Clear Aligner, representing approximately 80% of net revenues, and Systems and Services, accounting for the remaining 20%. The company leverages the Align Digital Platform to integrate Invisalign clear aligners, iTero intraoral scanners, and exocad CAD/CAM software into a seamless clinical workflow. Strategic growth is centered on increasing its 10% share of the 22 million annual global orthodontic case starts and expanding adoption among general practitioners and adult patients. Recent 2025 innovations include the iTero Lumina scanner, AI-powered Align X-ray Insights, and mandibular advancement solutions for Class II malocclusions. To enhance manufacturing efficiency, Align acquired Cubicure to transition toward direct 3D printing, reducing resin waste and mold dependency. Financial analysts should note significant exposure to macroeconomic volatility, including inflation and foreign exchange fluctuations, and geopolitical risks affecting operations in Israel, Mexico, and China. Competitive pressures are intensifying from traditional braces, emerging clear aligner rivals, and direct-to-consumer models. Additionally, the company faces operational vulnerability due to its reliance on single-source suppliers for critical resins and specialized optics. Regulatory compliance with the EU MDR, GDPR, and evolving AI standards is essential for maintaining global market access. |
| Feb 27, 2026 | risk_factors | Macroeconomic volatility, characterized by inflation and high interest rates, has suppressed discretionary spending and contributed to a four-year decline in orthodontic starts. This environment has driven a shift in patient preference from Invisalign clear aligners toward traditional wires and brackets. Geopolitical conflicts in Ukraine, the Middle East, and China, alongside tariff volatility in the U.S., China, Brazil, and Mexico, threaten supply chain stability and increase raw material and transportation costs. The iTero business remains specifically exposed to instability in Israel. In response to these headwinds, the company initiated a 2025 restructuring to optimize its global manufacturing footprint, which included workforce reductions and the planned sale of its Juarez, Mexico facility. Financial performance is further pressured by a product mix shift from higher to lower average selling price (ASP) offerings. Additionally, the company faces significant legal risks, including antitrust class actions and ongoing patent litigation with competitors such as Straumann and Angelalign. Foreign exchange volatility also remains a persistent risk given the company's substantial international revenue and the unpredictable fluctuations of the U.S. dollar against major currencies. |
Source: SEC EDGAR filing text and events; period Feb 27, 2026; filed Feb 27, 2026.
Continue research
Follow same-sector companies and source explainers connected to the research view.
A factual guide to SEC Form 8-K current reports and the material company events they can disclose between quarterly filings.
A factual guide to quarterly SEC Form 10-Q reports, how they differ from annual 10-K filings, and what readers can inspect first.
A factual guide to Form S-1 registration statements and the disclosures companies provide before a public offering.
A factual guide to the core 10-K sections investors use for company context: business description, risk factors, MD&A, financial statements, and segment disclosures.
